Back to Search
Norlestrin 21 2.5/50
by Barr Laboratories IncContraceptionCOCP
DiscontinuedGeneric

Estrogen

Ethinyl Estradiol

0.02Mg,0.03Mg,0.035Mg

Progestin

Norethindrone Acetate

1Mg,1Mg,1Mg

Regimen Protocol

Triphasic Pill 21 day

Androgenicity

Moderate

Approval Date

1/1/1982

Additives
None
Active Alternative Brands
Alternative brands with the same formulation that are actively prescribed

Barr Laboratories Inc(same manufacturer)

Tri-Legest Fe

Novast Laboratories Ltd

Chabelina Fe

Xiromed Llc

Norethindrone Acetate And Ethinyl Estradiol

Mayne Pharma Inc.

Tilia Fe

Have clinical questions about Norlestrin 21 2.5/50?

Get evidence-based, cited answers from our AI co-pilot for hormone health.

Try Dama Assist

© 2026 Dama Health. All rights reserved.

This tool is intended for use by licensed healthcare professionals. It provides reference information on FDA-approved contraception and hormone therapy products. Results should not be used as a substitute for clinical judgment. Data is sourced from the FDA Orange Book and other FDA-sourced resources and may contain errors or omissions.

Last updated: July 2025 | Powered by Dama Health | Terms of Use | Privacy Policy